A new government partnership plan to fast-track new medical products by piggybacking on international drug regulators risks turning the UK watchdog into a pharmaceutical industry “enabler,” a health pressure group is warning.
Chancellor Jeremy Hunt announced on Wednesday that £10 million will be given to the UK regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), to help streamline approvals for new medical products.
